Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Revenue

Neurocrine Biosciences had revenue of $622.10M in the quarter ending September 30, 2024, with 24.72% growth. This brings the company's revenue in the last twelve months to $2.24B, up 25.72% year-over-year. In the year 2023, Neurocrine Biosciences had annual revenue of $1.89B with 26.76% growth.

• Revenue (ttm): $2.24B
• Revenue Growth: +25.72%
• P/S Ratio: 5.50
• Revenue / Employee: $1,602,000
• Employees: 1,400
• Market Cap: 12.48B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.89B	398.40M	26.76%
Dec 31, 2022	1.49B	355.20M	31.34%
Dec 31, 2021	1.13B	87.60M	8.38%
Dec 31, 2020	1.05B	257.80M	32.71%
Dec 31, 2019	788.10M	336.90M	74.67%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.